CPSF6 Activators
CPSF6 activators represent a distinct chemical class with the ability to modulate cellular processes through the activation of Cleavage and Polyadenylation Specificity Factor 6 (CPSF6). The mechanism of action involves the interaction of these activators with CPSF6, a key component of the pre-mRNA 3' end processing machinery. By engaging with CPSF6, these compounds facilitate enhanced cleavage and polyadenylation of pre-mRNA molecules within the cell. Moreover, the mode of action extends beyond a simple binding event. CPSF6 activators may induce allosteric changes in CPSF6, affecting its overall structure and function. The intricacies of these structural alterations are essential for understanding how these compounds facilitate the efficient processing of pre-mRNA. Advanced techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy can be employed to capture detailed images of the molecular interactions between CPSF6 and its activators, providing a comprehensive view of the mechanisms at play.
The specific methods employed by CPSF6 activators can be elucidated by examining their structural characteristics and binding affinities. These activators typically feature chemical moieties that enable them to bind selectively to CPSF6, triggering a cascade of events that culminate in the efficient processing of pre-mRNA. The binding affinity is crucial for the effectiveness of these activators, as a strong interaction with CPSF6 ensures a robust and targeted response. Furthermore, structural studies can shed light on the precise binding sites and conformational changes induced by CPSF6 activators, offering insights into the intricate details of their mode of action. Overall, the elucidation of these molecular mechanisms provides a foundation for understanding how CPSF6 activators function at the cellular level, contributing to the advancement of knowledge in the field of RNA processing modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cyclic adenosine monophosphate (cAMP). Enhanced cAMP levels can stimulate the PKA pathway, which can positively influence the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can enhance the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine triggers the activation of adenylyl cyclase through G-protein coupled receptors, leading to enhanced cAMP levels. Increased cAMP levels can stimulate the PKA pathway, which can stimulate the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that degrade cAMP. By inhibiting these enzymes, IBMX increases intracellular cAMP levels, which can stimulate the PKA pathway and consequently enhance the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase-4 inhibitor. By inhibiting PDE4, Rolipram increases intracellular cAMP levels, which can stimulate the PKA pathway and enhance the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta adrenergic agonist which activates adenylyl cyclase and thereby increases cAMP levels. Increased cAMP can stimulate the PKA pathway, and consequently enhance the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine is a non-selective phosphodiesterase inhibitor. By inhibiting phosphodiesterases, Papaverine increases cAMP levels, stimulating the PKA pathway and consequently enhancing the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual-selective phosphodiesterase 3/4 inhibitor. By inhibiting PDE3 and PDE4, Zardaverine increases cAMP levels, stimulating the PKA pathway and consequently enhancing the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through D1-like receptors, stimulates the production of cAMP. Increased cAMP levels stimulate the PKA pathway which enhances the RNA processing activities of Cleavage and polyadenylation specificity factor subunit 6. | ||||||